← All trials
NCT07153289
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2026
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2028
- First posted
- Sep 3, 2025
- Last posted
- Sep 3, 2025
- Enrollment
- 38
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TuebingenLead sponsor
- Miltenyi Biotec, Inc.Collaborator
- University of FreiburgCollaborator
- University of HeidelbergCollaborator
- Julius-Maximilians UniversityCollaborator
- Berlin Institute of HealthCollaborator
- Technical University of MunichCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.